newsfilter
← Latest News
GlobeNewswire·

Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023 and Business Update

WESTPORT, Conn., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ:PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and in combination, today